Sanofi, GSK to supply COVAX with 200 mn doses of COVID-19 vaccine
New Delhi: Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, ...
Read moreDetails
New Delhi: Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, ...
Read moreDetailsLondon: Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX ...
Read moreDetailsLondon: Sanofi and GlaxoSmithKline say they are beginning human trials of a potential vaccine for COVID-19 after positive results from ...
Read moreDetails
By Dilip Cherian A 10-officer reshuffle at the Additional Secretary level may look like routine housekeeping, but if you look...
Read moreDetails
Lately, the Supreme Court’s intervention in high-profile cases does not necessarily arouse confidence and reassurance that wrongs may be righted....
Read moreDetails
The recent meeting between US President Donald Trump and Chinese President Xi Jinping turned out to be a rather tame...
Read moreDetails
After remaining deafeningly silent on a media report casting serious doubts about the fairness and functioning of the Election Commission...
Read moreDetails
